The Europe Radiation Oncology Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The likelihood that a cancer patient would survive is significantly increased by early cancer identification. Early diagnosis of cancer requires using molecular markers to identify potential signs and taking swift action. The demand for radiology oncology is anticipated to increase as a result of an increasing number of campaigns by various NGOs and supportive actions by various government entities to educate people about cancer symptoms.
Government funding and allocation policies, initiatives, and oncology treatment device acceptance are anticipated to be significant drivers of the radiation oncology market's revenue growth over the next several years. The use of ionizing radiation to treat various malignancies as well as benign illnesses gave rise to the area of radiation oncology immediately after the discovery of X-rays and their effects on tissue in 1895. Initially, treatments were frequently administered in single doses using radium-filled glass tubes or low-energy cathode ray tubes placed close to tumors.
Lung cancer develops when abnormal cells in one or both lungs continue to grow unchecked. People who smoke have the greatest risk of acquiring lung cancer, while it can also afflict nonsmokers. The quantity and frequency of smoking affect a patient's risk of developing lung cancer. Additional risk factors include exposure to secondhand smoking, asbestos, some metals, some organic compounds, air pollution, radiation, and diesel exhaust at work or in the environment. The International Agency for Research on Cancer (IARC) has produced predictions of cancer incidence and death called GLOBOCAN 2020.
The Germany market dominated the Europe Radiation Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $837.5 million by 2028.The UK market is anticipated to grow at a CAGR of 6.9% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 8.6% during (2022 - 2028).
Based on Application, the market is segmented into Breast Cancer, Gynecological Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Head & Neck Cancer, Gynecological Cancer and Others. Based on Type, the market is segmented into External Beam Radiation Therapy and Internal Beam Radiation Therapy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Radiation Oncology Market will Hit $12.8 Billion by 2028, at a CAGR of 8.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Varian Medical Systems, Inc., Ion Beam Applications SA, Elekta AB, Accuray Incorporated, Nordion Inc. (Sotera Health LLC), Isoray Inc., Mevion Medical Systems, Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.
By Application
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
